Search

Your search keyword '"Debouverie, Marc"' showing total 457 results

Search Constraints

Start Over You searched for: Author "Debouverie, Marc" Remove constraint Author: "Debouverie, Marc"
457 results on '"Debouverie, Marc"'

Search Results

4. Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study

5. Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis After Fingolimod Withdrawal

7. Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference

9. Comparison of 2 Methods for Estimating Multiple Sclerosis–Related Mortality

11. Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data

12. Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

13. Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis.

14. Effects of High- and Low-Efficacy Therapy in Secondary Progressive Multiple Sclerosis

16. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

18. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.

19. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

20. Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study

21. The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial

22. Historique de la sclérose en plaques

23. Immunologie de la sclérose en plaques

24. Épidémiologie, environnement et génétique dans la sclérose en plaques

25. Histoire naturelle de la sclérose en plaques

26. The radiologically isolated syndrome: revised diagnostic criteria

27. Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis

28. Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: a retrospective observational cohort study

30. Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis

33. Evaluation of the quality of the care pathway for patients with multiple sclerosis in France: Results of an original study of a cohort of 700 patients

34. Prospective Characterization of Brain T2 Lesions Suggestive of Demyelination in Asymptomatic Patients diagnosed as Radiologically Isolated Syndrome (P14-4.011)

37. Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference.

38. Comparative effectiveness of dimethyl fumarate in multiple sclerosis

39. The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies

40. Adult-onset genetic leukoencephalopathies: A MRI pattern-based approach in a comprehensive study of 154 patients

41. Comparative effectiveness of natalizumab and fingolimod in subgroups of patients with relapsing-remitting multiple sclerosis from three international cohorts

42. Disability progression in multiple sclerosis patients using early first‐line treatments.

44. Mass Cytometry Identifies Expansion of T-bet+ B Cells and CD206+ Monocytes in Early Multiple Sclerosis

45. Aquaporin 4 distribution in the brain and its relevance for the radiological appearance of neuromyelitis optica spectrum disease

46. Additional file 1 of Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data

47. Additional file 2 of Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data

48. sj-pdf-1-msj-10.1177_1352458520980366.pdf – Supplemental material for Cumulative effects of therapies on disability in relapsing multiple sclerosis

49. sj-pdf-1-msj-10.1177_1352458520981300 – Supplemental material for Determinants of therapeutic lag in multiple sclerosis

50. The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies

Catalog

Books, media, physical & digital resources